Resveratrol counteracts systemic and local inflammation involved in early abdominal aortic aneurysm development

Daniela Palmieri, Bianca Pane, Chiara Barisione, Giovanni Spinella, Silvano Garibaldi, Giorgio Ghigliotti, Claudio Brunelli, Ezio Fulcheri, Domenico Palombo

Research output: Contribution to journalArticle

Abstract

Background: Monocyte activation, macrophage infiltration, vascular oxidative stress and matrix proteolysis are inflammatory key steps contributing to abdominal aortic aneurysm (AAA) development. A phenotypical and functional heterogeneity is recognizable in monocytes by the differential expression of surface molecules: CD62L- subset corresponds to activated monocytes, while CD143/ACE surface expression increases during their differentiation into macrophages. In this work, Resveratrol, which is an antioxidant polyphenol with vasoprotective properties, has been evaluated for its potential to limit aneurysm development and monocyte-dependent inflammatory response in a model of elastase-induced AAA. Methods: Male Sprague-Dawley rats received Resveratrol (10 mg/kg/die) (Rsv group, n = 15) or vehicle (ethanol) alone (Et-OH group, n = 15) continuously from 7 d before until 14 d after the AAA induction with elastase; five littermates were used as untreated control group (Ctr group, n = 5). At the end of treatment, CD143 and CD62L monocyte expression was analyzed by flow cytometry, serum antioxidant capacity was evaluated using the TRAP method and circulating TNFα, and MMP-9 were measured with ELISA and gel zymography, respectively. Aortas were subjected to histology and immunohistochemistry for morphological analysis, macrophage infiltration, and MMP-9, TNFα, and VEGF expression. Results: Resveratrol counteracted the CD62L-monocyte subset expansion, CD143 monocyte expression, and circulating levels of MMP-9 activity and TNFα associated to AAA induction. Similarly, treatment with Resveratrol significantly attenuated AAA expansion, vessel wall macrophage infiltration and MMP-9, VEGF, and TNFα expression, compared with AAA from Et-OH group. Conclusions: Resveratrol limited the monocyte-dependent inflammatory response, macrophage differentiation and aortic lumen enlargement in elastase-induced AAA. These data suggest that Resveratrol might be tested in selected patients with small AAA to modulate the early systemic and local inflammatory response associated to AAA progression.

Original languageEnglish
JournalJournal of Surgical Research
Volume171
Issue number2
DOIs
Publication statusPublished - Dec 2011

Keywords

  • abdominal aortic aneurysm (AAA)
  • ACE/CD143
  • CD62L
  • macrophages
  • MMP-9
  • monocytes
  • Resveratrol
  • TNFα
  • VEGF

ASJC Scopus subject areas

  • Surgery

Fingerprint Dive into the research topics of 'Resveratrol counteracts systemic and local inflammation involved in early abdominal aortic aneurysm development'. Together they form a unique fingerprint.

  • Cite this

    Palmieri, D., Pane, B., Barisione, C., Spinella, G., Garibaldi, S., Ghigliotti, G., Brunelli, C., Fulcheri, E., & Palombo, D. (2011). Resveratrol counteracts systemic and local inflammation involved in early abdominal aortic aneurysm development. Journal of Surgical Research, 171(2). https://doi.org/10.1016/j.jss.2011.07.041